Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of ZOLL Medical Corporation (“ZOLL” or the “Company”) (Nasdaq: ZOLL) relating to the proposed acquisition by Asahi Kasei Corporation (“Asahi”).
Under the terms of the transaction, ZOLL shareholders would receive $93.00 in cash for each share of ZOLL stock they own. The investigation concerns possible breaches of fiduciary duty and other violations of state law by the Board of Directors of ZOLL for not acting in the Company’s shareholders' best interests in connection with the sale process to Asahi. The transaction may undervalue ZOLL as a result of failing to adequately shop the Company. The price being paid by Asahi is both below the premium paid in comparable transactions and below an analyst $100.00 per share price target.
If you own shares of ZOLL stock and wish to discuss the legal ramifications of the proposed transaction, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at email@example.com, visiting http://brodsky-smith.com/395-zoll-zoll-medical-corporation.html, or by calling toll free 877-LEGAL-90.